Background:. Arterial resection (AR) during pancreatectomy for curative R0 resection of pancreatic ductal adenocarcinoma (PDAC) remains a controversial procedure with high morbidity. Objective:. To investigate the feasibility and oncological outcomes of pancreatectomy combined with AR at a high-volume center for pancreatic surgery. Methods:. We retrospectively analyzed our experience in PDAC patients, who underwent pancreatic resection with AR and/or venous resection (VR) between 2007 and 2021. Results:. In total 259 PDAC patients with borderline resectable (n = 138) or locally advanced (n = 121) PDAC underwent vascular resection during tumor resection. From these, 23 patients had AR (n = 4 due to intraoperative injury, n = 19 due to suspec...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...
Pancreatic cancer is associated with a poor prognosis, and surgical resection remains the only chanc...
Background: Pancreatic ductal adenocarcinoma (PDAC) patients frequently present with borderline rese...
Background: Few studies have investigated the outcome of pancreatectomy associated with artery resec...
Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related mortality in the Western worl...
Pancreatic cancer is the 4th cancer-related cause of death in Western countries and it is expected t...
BACKGROUND: Pancreatic tumors are frequently diagnosed in a locally advanced stage with poor prognos...
This literature review aimed to critically analyze oncological results of vascular resection during ...
BACKGROUND: Pancreaticoduodenectomy (PD) is the only chance of cure for periampullary cancers. This ...
This manuscript summarizes an excellent debate from the 2021 SSAT/Pancreas Club symposium on arteria...
OBJECTIVE: Combined vascular and pancreatic resection improves long-term survival of patients suffer...
International audienceBackground: Resectability of pancreatic carcinoma (PC) is directly linked to v...
Minimally invasive pancreatic surgery is eventually gaining momentum, but concerns remain regarding ...
For pancreatic ductal adenocarcinoma (PDAC) of the head and/or body invading the splenic artery (SA)...
For pancreatic ductal adenocarcinoma (PDAC) of the head and/or body invading the splenic artery (SA)...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...
Pancreatic cancer is associated with a poor prognosis, and surgical resection remains the only chanc...
Background: Pancreatic ductal adenocarcinoma (PDAC) patients frequently present with borderline rese...
Background: Few studies have investigated the outcome of pancreatectomy associated with artery resec...
Pancreatic cancer (PDAC) is the fourth leading cause of cancer-related mortality in the Western worl...
Pancreatic cancer is the 4th cancer-related cause of death in Western countries and it is expected t...
BACKGROUND: Pancreatic tumors are frequently diagnosed in a locally advanced stage with poor prognos...
This literature review aimed to critically analyze oncological results of vascular resection during ...
BACKGROUND: Pancreaticoduodenectomy (PD) is the only chance of cure for periampullary cancers. This ...
This manuscript summarizes an excellent debate from the 2021 SSAT/Pancreas Club symposium on arteria...
OBJECTIVE: Combined vascular and pancreatic resection improves long-term survival of patients suffer...
International audienceBackground: Resectability of pancreatic carcinoma (PC) is directly linked to v...
Minimally invasive pancreatic surgery is eventually gaining momentum, but concerns remain regarding ...
For pancreatic ductal adenocarcinoma (PDAC) of the head and/or body invading the splenic artery (SA)...
For pancreatic ductal adenocarcinoma (PDAC) of the head and/or body invading the splenic artery (SA)...
BACKGROUND: Resectable pancreatic ductal adenocarcinoma continues to carry a poor prognosis. Of the ...
Pancreatic cancer is associated with a poor prognosis, and surgical resection remains the only chanc...
Background: Pancreatic ductal adenocarcinoma (PDAC) patients frequently present with borderline rese...